GAMMA Investing’s Caribou Biosciences CRBU Stock Holding History

GAMMA Investing’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.35K	Buy	+1,066	New	+$1.67K	﹤0.01%	4042
2024 Q2	–	Sell	-262	Closed	-$1.35K	–	3467
2024 Q1	$1.35K	Buy	262 +195	+291%	+$1.2K	﹤0.01%	2871
2023 Q4	$411	Buy	+67	New	+$331	﹤0.01%	3001

Other funds holding CRBU

GAA

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's CRBU Position: Q3 2026 in Review

GAMMA Investing opened a new position in Caribou Biosciences (CRBU) in Q3 2026: 1,066 shares worth $1.35K. The stake represents ﹤0.01% of the portfolio and ranks #4042 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in CRBU as recently as Q1 2024.

GAMMA Investing first reported a position in CRBU in Q4 2023 and has held it in 3 quarters since. 3 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.

GAMMA Investing held 1,066 shares of Caribou Biosciences worth $1.35K as of Q3 2026.
Caribou Biosciences was a new GAMMA Investing position in Q3 2026.
Caribou Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4042 holding.
GAMMA Investing first reported a position in Caribou Biosciences in Q4 2023 and has held it in 3 quarters since.
3 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.